SB 730 amends Pennsylvania law regarding end-of-life medical decisions, affecting patients, their designated surrogates, and healthcare providers, including emergency medical services. The bill introduces and integrates "Pennsylvania orders for life-sustaining treatment" (POLST) into the existing framework, alongside advance health care directives and out-of-hospital do-not-resuscitate (OOH-DNR) orders. It updates definitions for various healthcare roles to align with current state law and modifies criminal penalties for actions like falsifying or interfering with these medical orders. Additionally, the bill clarifies the applicability of emergency medical services in situations without an OOH-DNR order and standardizes the issuance of OOH-DNR orders, bracelets, and necklaces by physicians.
HB 226, the Protection of Patients and Medical Personnel from Health Care Facility Retaliation Act, prohibits healthcare facilities from retaliating against patients or medical personnel who file complaints, report issues, or participate in investigations. It creates rebuttable presumptions that negative actions (like discharge or demotion) taken within 120 days of a complaint by medical staff or 180 days for patients are retaliatory unless proven otherwise. Violators face civil penalties up to $25,000 per violation, potential license suspension, and criminal misdemeanor charges for willful violations, with remedies including reinstatement, lost wages, and legal costs for affected individuals. The law directly affects patients, healthcare workers, and facilities operating under Pennsylvania's Health Care Facilities Act.
SB 946 adds tianeptine - a medication sometimes used for depression but with abuse risks - to Pennsylvania's Schedule II of controlled substances, placing it in a high-risk category due to its potential for abuse and dependence. The bill requires the Pennsylvania Department of Health to monitor tianeptine-related health issues (like overdoses, seizures, or withdrawal symptoms) by collecting data from hospitals, poison control centers, and law enforcement. It also empowers the department to issue public safety advisories and establish reporting rules for healthcare providers. This directly affects tianeptine users, healthcare facilities, and public health officials, focusing on tracking health impacts rather than restricting access immediately. The bill takes effect 60 days after enactment.
SB 604 authorizes Pennsylvania to join the Counseling Compact, a multi-state agreement allowing licensed professional counselors to practice across participating states without obtaining separate licenses. This directly affects licensed counselors - especially those serving military families who relocate frequently - and their clients in member states. Key provisions include mutual recognition of licenses, standardized disciplinary processes, and support for telehealth services to improve access to counseling. The compact eliminates the need for counselors to hold multiple state licenses while ensuring accountability under each state’s practice laws where the client is located.
This resolution designates September 2025 as "Prostate Cancer Awareness Month" in Pennsylvania. It symbolically raises public attention to prostate cancer, highlighting statistics like an estimated 13,000 new cases and 1,500 deaths in Pennsylvania during 2025. The resolution also urges Congress to support federal legislation (H.R. 1300) that would require health insurance coverage for prostate cancer screenings without cost-sharing for at-risk men. It does not create new laws or funding but aims to promote awareness and encourage preventive care.
Senate Resolution 88 recognizes the week of April 20 through 26, 2025, as "National Infertility Awareness Week" in Pennsylvania. This resolution aims to raise awareness about infertility, which affects many couples, and support efforts to remove barriers to care and reduce stigma.
HB 1656 requires facilities serving vulnerable populations (like nursing homes, shelters, or group homes) to improve indoor air quality through specific measures. It provides tax credits to help these facilities cover costs for air quality upgrades, establishes certification programs for facilities meeting standards, and funds public education campaigns about air quality benefits. The bill also mandates the Department of Health to collect data on indoor air quality conditions across these facilities. These provisions aim to create cleaner indoor environments for residents without specifying outcome predictions.
HB 1283 establishes the Integrated Student Supports Program and Fund, aiming to enhance K-12 student academic success and increase graduation rates in Pennsylvania public schools by removing academic and nonacademic barriers. The Department of Education will designate a third-party nonprofit organization to provide evidence-based community school services, covering areas like mental health support, college and career preparation, and parental engagement. The bill allows the Department to award competitive, dollar-for-dollar matching grants from the new fund to public school entities that develop strategic plans for implementing these integrated student supports. The designated organization will be required to submit annual reports on program outcomes, including graduation rates and student attendance.
SB 732 amends Pennsylvania's Medical Marijuana Act, updating provisions related to medical marijuana use in the workplace for certified patients, employers, and job applicants. The bill introduces specific definitions for "impaired," "under the influence," and "safety-sensitive positions" to clarify employment standards. It removes some prior blanket prohibitions on patients performing certain duties while under the influence and instead focuses on defined impairment and drug testing. Employers are permitted to require drug tests for safety-sensitive roles and make employment decisions based on test results or refusal to test.
HB 69 amends Pennsylvania's Cancer Drug Repository Program to allow unused, unopened cancer prescription drugs to be redistributed to indigent patients through approved pharmacies. The bill updates definitions (e.g., clarifying "cancer drug" includes drugs treating cancer or its side effects), requires drugs to be in original sealed packaging with unexpired dates, and mandates the State Board of Pharmacy to maintain a list of approved participating pharmacies. It also adds requirements for annual reporting and establishes procedures for restocking and dispensing drugs while maintaining safety standards. This directly affects indigent cancer patients seeking affordable medication and pharmacies participating in the program.
